Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration.

18α-Glycyrrhizic acid 是甘草酸的衍生物。18α-Glycyrrhizic acid 具有较弱的抗肝毒性抗炎活性。

WAY-616296 是一种活性分子。